|
Drug patents worth $60bn to expire in 4 years
(Cached)
|
12.3.2010 |
TOI: India Business |
| Nearly $60 billion worth of patents for drugs is set to expire in the next four years across the world and Indian pharmaceutical companies are now in a position to take a major share of this pie, industry members said. |
|
Also found in:
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
|
|
Solar powered ATMs from Vortex Engineering
(Cached)
|
12.3.2010 |
Hindu: Business |
| |
|
Also found in:
[prashantiyengar :: everywhere]
[berkan :: Renewables]
[berkan :: Solar]
[chvartak :: Solar]
[sandman1965 :: Solar]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[venkatkanchi :: Solar]
[venkatkanchi :: Renewables]
[sivakumar :: Solar]
[sivakumar :: Renewables]
[vishwas :: india]
[vishwas :: everywhere]
[subbu :: Solar]
[Abhijeetvj :: Solar]
[Abhijeetvj :: Renewables]
[thinthu :: Solar]
[nwct :: renewable]
[nwct :: Solar]
[TahirAmin :: india]
[TahirAmin :: everywhere]
|
|
Now, shorter ‘T20 bats'
(Cached)
|
12.3.2010 |
HBL: Marketing |
| Mongoose Cricket on Thursday launched its range of bats, “designed specifically for Twenty20” in |
|
Also found in:
[rgooba07 :: Cricket]
[vishwas :: india]
[vishwas :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[prashantiyengar :: everywhere]
[nilaymedh :: law]
[TahirAmin :: india]
[TahirAmin :: everywhere]
|
|
Indian-American professor honoured in US
(Cached)
|
11.3.2010 |
Rediff: News |
| Indian-American professor, Manoranjan 'Mano' Misra, at University of Nevada, Reno (UNR), has been honoured by the Nevada System of Higher Education Board of Regents for his research works. |
|
Also found in:
[arghyam :: All-News]
[arghyam :: Quality]
[arghyam :: DrinkingWater]
[arghyam :: WaterQuality]
[subbu :: Solar]
[Abhijeetvj :: Solar]
[Abhijeetvj :: Renewables]
[thinthu :: Solar]
[berkan :: Renewables]
[berkan :: Solar]
[vishwas :: india]
[vishwas :: everywhere]
[sandman1965 :: Hydel]
[sandman1965 :: Solar]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[chvartak :: Solar]
[Genecampaign :: ge-gm]
[sailendram :: All-News]
[sailendram :: Quality]
[sivakumar :: Solar]
[sivakumar :: Renewables]
[nwct :: renewable]
[nwct :: Solar]
[fredericknoronha :: water]
[prashantiyengar :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[kjrajesh :: Media]
[venkatkanchi :: Solar]
[venkatkanchi :: Renewables]
|
|
Time for drug giants to jump into the patent pool?
|
10.3.2010 |
The Guardian -- World Latest |
| While drugmaking giant GlaxoSmithKline has picked up a load of good press for CEO Andrew Witty's developing world initiatives - from ploughing back some of the (tiny) profits made in Africa to the more interesting patent pool it announced for neglected tropical diseases - it is Californian rival Gilead that gets a higher approval rating at the moment from Aids campaigners. Gilead has at least nominally embraced the idea of a patent pool for HIV drugs, which the donor organisation UNITAID is currently attempting to set up. GSK says it is interested in the concept and happy to talk, but the language is just a tad more reserved.
For those who have not been immersed in the jargon of the HIV drug struggle over the past few years, incidentally, a ... |
|
Also found in:
[jashmit :: Emergency]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[rakujha :: social-defence]
|
|
'Our Indian operations are a great success story'
(Cached)
|
10.3.2010 |
Rediff: Business |
| Andrew Witty, chief executive of GlaxoSmithKline (GSK), the world's second-largest drug company, was in India this week as part of the dedication of an albandazole manufacturing facility at Nashik to the World Health Organization (WHO)'s global programme to eliminate Lymphatic Filariasis. |
|
Also found in:
[pradeepbv :: OpenNGO]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[sandman1965 :: Deals]
|
|
GlaxoSmithKline stays confident on patent regime
(Cached)
|
10.3.2010 |
Financial Express: Front Page |
| At a time when multinational innovator drug companies and global pharma associations cry hoarse over the intellectual property regime in India, GlaxoSmithKline, the second largest pharma firm in the world, remains confident over the country's patent scenario. |
|
Also found in:
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[nilaymedh :: ipo]
[indiatogether :: Health]
[sandman1965 :: Realty]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[esg :: All]
[esg :: Cancer]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
|
|
Strides buys Aspen unit for $75 m
(Cached)
|
5.3.2010 |
DNA: Money |
| The Brazilian deal is estimated to deliver $40 million on an annualised basis. |
|
Also found in:
[esg :: All]
[esg :: Cancer]
[sandman1965 :: Deals]
[ind32 :: Indian startups]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vj712 :: Indian startups]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[meerak :: bengaluru business]
[meerak :: Bengaluru business]
|
|
Pharma cos filing multiple patents for same drug
(Cached)
|
5.3.2010 |
DNA: Money |
| This increases chances of a win, but adds to the burden on patent offices. |
|
Also found in:
[nilaymedh :: law]
[esg :: All]
[esg :: Diabetes]
[esg :: HIV]
[rakujha :: social-defence]
[indiatogether :: Health]
[ind32 :: Indian startups]
[sandman1965 :: Realty]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vj712 :: Indian startups]
[kolcarto :: Kolkata]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
|
|
How pharma can use deduction as addition
(Cached)
|
5.3.2010 |
Financial Express: Front Page |
| Pharmaceutical companies got a much sought-after wish granted when FM Pranab Mukherjee said in his Budget speech for 2010-11 that companies spending on in-house research... |
|
Also found in:
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
|
|
Natco moves SC against Novartis drug
(Cached)
|
5.3.2010 |
Financial Express: Front Page |
| Natco Pharma has approached the Supreme Court challenging a part of the Intellectual Property Appellate Board's decision that said Swiss drug-maker Novartis' blood cancer drug Glivec was novel and inventive. |
|
Also found in:
[esg :: All]
[esg :: Cancer]
[indiatogether :: Health]
[sandman1965 :: Realty]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[prs :: Acts]
[prs :: Acts-Central]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
|
|
The absurd MNC-backed 'India Project'
(Cached)
|
4.3.2010 |
Rediff: Business |
| MNC-backed IP summits try to influence sitting judges on patent law enforcement issues pending in Indian courts. |
|
Also found in:
[sandman1965 :: Realty]
[nilaymedh :: law]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[pwdc :: All-States]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[newstrust :: Trade]
[newstrust :: India and Global Economy]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[TOM :: All-States]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: india]
[vishwas :: everywhere]
[vj712 :: Indian startups]
[ind32 :: Indian startups]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[avyakto :: Law]
[newstrust :: case law]
[newstrust :: Supreme Court]
|
|
Process patent granted for drug developed by IIT-M, Madras Institute of Nephrology
(Cached)
|
4.3.2010 |
Hindu: Tamil Nadu |
| |
|
Also found in:
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[ssurekha :: news]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
|
|
Ranbaxy fails to get FDA nod for Flomax, misses exclusive rights
(Cached)
|
4.3.2010 |
Financial Express: Front Page |
| Ranbaxy Laboratories on Wednesday said it has failed to get the US health regulator's nod for launching generic version of Flomax, a prostrate drug, thereby missing the opportunity to... |
|
Also found in:
[ind32 :: Indian startups]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[vj712 :: Indian startups]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
|
|
Process patent for drug developed by IIT-M, Madras Institute of Nephrology
(Cached)
|
4.3.2010 |
Hindu: Tamil Nadu |
| |
|
Also found in:
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[ssurekha :: news]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
|
|
Will Dr Reddy's 3-point strategy succeed in India?
(Cached)
|
3.3.2010 |
Rediff: Business |
| Some time in mid-March, Dr Reddy's Laboratories will reach a new landmark: Its sales in India will cross the Rs 1,000-crore mark. |
|
Also found in:
[nwct :: Healthcare]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[ind32 :: Indian startups]
[vj712 :: Indian startups]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
|
|
Supreme Court admits Bayer patent-linkage plea
(Cached)
|
2.3.2010 |
DNA: Money |
| Bayer appealed to the apex court after the division bench of the Delhi High Court dismissed the German firm's appeal on the issue on February 9. |
|
Also found in:
[indiatogether :: Health]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[sandman1965 :: Realty]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[nilaymedh :: law]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
|
|
SC rejects Bayer’s plea to stay Cipla’s cancer clone
(Cached)
|
2.3.2010 |
ET: Pharma |
| The Supreme Court turned down a request by German drugmaker Bayer AG to stop Mumbai-based Cipla from launching the low-cost version of Bayer’s patented cancer medicine Nexavar while admitting the case. |
|
Also found in:
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[nwct :: Healthcare]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[indiatogether :: Health]
|
|
No interim stay on Cipla’s Nexavar clone
(Cached)
|
1.3.2010 |
ET: Pharma |
| The Supreme Court turned down a request by German drugmaker Bayer AG to stop Mumbai-based Cipla from launching the low-cost version of Bayer’s patented cancer medicine Nexavar while admitting the case. |
|
Also found in:
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[indiatogether :: Health]
[nwct :: Healthcare]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
|
|
Pharma sector untouched by recession
(Cached)
|
1.3.2010 |
Hindu:Education Plus: Hyderabad |
| |
|
Also found in:
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: everywhere]
[vishwas :: india]
[nilaymedh :: teaching]
[nwct :: Healthcare]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[ind32 :: Indian startups]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[vj712 :: Indian startups]
|
